My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Anales de Psicología
On-line version ISSN 1695-2294Print version ISSN 0212-9728
Abstract
MAYA-PINA, Lucía-Verónica et al. Mental health impact by COVID-19 in hospitalized patients sample in Mexico City. Anal. Psicol. [online]. 2022, vol.38, n.3, pp.448-457. Epub Oct 16, 2023. ISSN 1695-2294. https://dx.doi.org/10.6018/analesps.502711.
One of the consequences of pandemic is the increase in the prevalence of mental alterations such as anxiety, depression and stress. Since here, we aimed to determinate through a transversal and observational study prevalence of stress, anxiety and depression within hospitalized patients by COVID-19 as well as their likely association with the emotional impact received by relatives with hospitalized patients by COVID-19. Forty-five COVID-19 hospitalized patients with mean age of 54.4 ± 9.6 years and fifty-five relatives with mean age of 43.2 ± 11.8 years answered a questions battery and DASS-21 survey. Our results revealed high prevalence of depression, anxiety and stress assessed by DASS-21 subscales. We also identified risk factors associated with the emotional health such as age (< 50 years: depression OR = 2.99 (1.31, 6.80), p < .05 and anxiety OR = 2.83 (1.15, 6.93), p < .05), by gender (female: anxiety OR = 4.13 (1.57, 10.89), p < .05 and stress OR = 5.38 (2.27, 12.8), p < .05), by group of study (relatives: depression OR = 3.83 (1.63, 8.96); p < .05, anxiety OR = 3.60 (1.46, 8.88); p < .05 and stress OR = 3.30 (1.41, 7.70); p < .05). Additionally, female gender and low socioeconomic status in patients (β = 3.23; 1.96) and relatives (β = 1.86; 2.31) were associated with higher scores in anxiety (p < .05) and stress (p < .05). We concluded that our sample of COVID-19 patients maintain a high prevalence of mental alterations and age, gender and socioeconomic status modify the magnitude of these disorders.
Keywords : DASS-21; Anxiety; Stress; Depression; COVID-19.